Purchases and Sales Made in Q2 2023 in Virpax Pharmaceuticals, Inc. (VRPX)
This table provides information about the institutional ownership of Virpax Pharmaceuticals, Inc. (VRPX) during Q2 2023. The information is specifically focused on institutions that hold shares of Virpax Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Two Sigma Securities, LLC
New York, NY |
BUY
|
- |
12KNew |
$7.65K - $13K
|
12K
$7.29K
|
|
|
Aug 15, 2023
Q2 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
2+ 3.33% |
$1.28 - $2.18
|
62
$37.8
|
|
|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 14, 2023
Q2 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-30- 0.55% |
$19.2 - $32.7
|
5.43K
$3.31K
|
|
|
Aug 11, 2023
Q2 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-5.95K- 6.24% |
$3.81K - $6.48K
|
89.4K
$54.5K
|
|
|
Aug 14, 2023
Q2 2023
|
Sabby Management, LLC
Upper Saddle River, NJ |
SELL
|
- |
-301K- 42.98% |
$193K - $329K
|
400K
$244K
|